116 related articles for article (PubMed ID: 1222395)
1. Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma.
Kane RC; Cohen MH; Broder LE; Bull MI; Creaven PJ; Fossieck BE
Cancer Chemother Rep; 1975; 59(6):1171-2. PubMed ID: 1222395
[No Abstract] [Full Text] [Related]
2. Cyclophosphamide plus emetine in lung cancer.
Street EW
Lancet; 1972 Aug; 2(7773):381-2. PubMed ID: 4114753
[No Abstract] [Full Text] [Related]
3. Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Panettiere F; Coltman CA
Cancer; 1971 Apr; 27(4):835-41. PubMed ID: 4929936
[No Abstract] [Full Text] [Related]
4. Cyclophosphamide plus emetine in lung cancer.
Hyde KR; Marsh K; Perry W
Lancet; 1972 Aug; 2(7774):427. PubMed ID: 4115244
[No Abstract] [Full Text] [Related]
5. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
Takita H; Brugarolas A; Mittelman A; Vincent R
Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
[No Abstract] [Full Text] [Related]
6. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
7. Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study.
Brugarolas A; Lacave AJ; Ribas A; Miralles MT
Eur J Cancer (1965); 1978 May; 14(5):501-5. PubMed ID: 348479
[No Abstract] [Full Text] [Related]
8. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
Hutcheon AW; Palmer JB; Pratt MA; Clark RA
Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
[No Abstract] [Full Text] [Related]
9. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
[No Abstract] [Full Text] [Related]
10. An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung.
Gottlieb JA; Serpick AA
Cancer Chemother Rep; 1970 Oct; 54(5):369-71. PubMed ID: 5514626
[No Abstract] [Full Text] [Related]
11. [Does chemotherapy bring real benefit to patients with inoperable bronchial epidermoid cancer?].
Depierre A
Rev Mal Respir; 1986; 3(4):169-71. PubMed ID: 3786923
[No Abstract] [Full Text] [Related]
12. [Selective bronchial artery perfusion with cisplatin in the treatment of inoperable bronchogenic carcinoma].
Liu ZJ
Zhonghua Fang She Xue Za Zhi; 1987 Feb; 21(1):4-7. PubMed ID: 2954790
[No Abstract] [Full Text] [Related]
13. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
Host H
Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
[No Abstract] [Full Text] [Related]
14. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Brunner KW; Marthaler T; Müller W
Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
[No Abstract] [Full Text] [Related]
15. [Intra-arterial drug infusion via the bronchial artery in the treatment of bronchogenic carcinoma].
Wang ZT
Zhonghua Fang She Xue Za Zhi; 1988 Aug; 22(4):216-9. PubMed ID: 3145173
[No Abstract] [Full Text] [Related]
16. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report.
Tate CF; Viamonte M; Agnew JR
Am Rev Respir Dis; 1968 Apr; 97(4):685-93. PubMed ID: 4296229
[No Abstract] [Full Text] [Related]
17. Cytostatic infusion into bronchial arteries in bronchogenic carcinoma.
Ekholm S; Albrechtsson U; Hellekant C; Jonsson K; Nyman U; Tylén U
Ann Radiol (Paris); 1980; 23(4):346-8. PubMed ID: 7387096
[No Abstract] [Full Text] [Related]
18. Hexamethylmelamine in inoperable bronchogenic carcinoma.
Takita H
N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448
[No Abstract] [Full Text] [Related]
19. [Experience of photodynamic therapy in inoperable bronchogenic cancer in the city of Nancy. Apropos of 3 cases].
Feintrenie X; Lignon D; Arboit F; Ménard O; Jonveaux E; Martinet Y; Guillemin F
Rev Pneumol Clin; 1992; 48(3):129-30. PubMed ID: 1439465
[No Abstract] [Full Text] [Related]
20. Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Jun; 10(3):234-6. PubMed ID: 3473923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
